IDEX Corporation provided earnings guidance for the year 2022. For the period, the company's organic sales growth is projected to be approximately 12% over the prior year period, with a 9 % organic sales increase in the fourth quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80 (adjusted EPS attributable to IDEX of $8.04 to $8.09).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
206.1 USD | -1.21% | -4.20% | -5.07% |
16/05 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
08/05 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.07% | 1.56TCr | |
-8.69% | 1.34TCr | |
+17.08% | 635.36Cr | |
-8.30% | 500.5Cr | |
+1.26% | 450.99Cr | |
+5.81% | 309.18Cr | |
+95.18% | 169.7Cr | |
+6.02% | 128.86Cr | |
+15.21% | 99Cr | |
-0.37% | 93Cr |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- Idex Corporation Provides Earnings Guidance for the Year 2022